Growth momentum is back
RESULTS
Need To Know
- Earnings and dividend ahead of expectations, with resident policyholders returning to growth, in-line with guidance
- Expecting moderation in industry resident policyholder growth, guiding to ~1.5-2.0% growth in FY24 and claims growth of ~2.6%
- With claims growth still remaining low and evidence of policyholder growth post the Cyber attack we retain our Buy
FY23 results overview v consensus :
Revenue $7,355m vs $7,204m
Underlying NPAT $499m vs $480m
EPS 18.1cps vs 17.6cps
DPS 8.3cps vs 8.0cps
Investment Implications
MPL’s underlying NPAT was ~4% ahead of consensus on strong investment income, partly offset by higher overheads and tax. Resident policyholder growth came in-line with guidance, growing 10.9k (+0.6%), with the majority of this attributable to ahm (MPL members down -0.1% 2H23 vs 1H23, ahm up +2.1%). Cybercrime related costs came in a touch above guidance at $46.4m (vs $40-45m). Further cyber related costs in FY24 are expected to be $30-35m as MPL continues improving its IT security and legal costs, however this excludes any potential findings or outcomes from regulatory investigations.
Resident policyholder growth is expected to continue to grow again in FY24 by ~1.5-2.0% as the industry growth moderates relative to FY23. We expect ahm to continue delivering the majority of growth. Forecast FY24 underlying claims growth at 2.6% is similar to underlying growth in FY23 of 2.4%, with healthcare cost inflation having a modest impact on claims. The major headwind for FY24 is higher public and private hospital claims inflation, partly offset by lower rehab claims. Management is also targeting $20m of productivity savings across FY24 and FY25.
Non-resident policyholder growth of 78.4k (+39.9%) was strong, and gross margin recovered to pre-Covid levels. Continued growth in visitor and worker market segments and market share opportunities provide additional room for growth.
The investment portfolio returns came in above expectations, although the underlying spread to the RBA cash rate of 91bps is still below the target of 150-200bps with property fund manager performances below benchmark. The balance sheet remains strong, with the capital ratio at 14.6%, allowing for the additional temporary $250m APRA supervisory adjustment. The final dividend also came in above expectations, with the payout ratio at 80.5%.
Investment View
Immigration is providing key non-resident policyholder growth for MPL, and it should continue to benefit from further immigration, evidenced by strong non-resident gross profit growth. The resident policyholder growth should see renewed momentum into FY24, and we expect the business to remain resilient post the cyberattack. We retain our Buy recommendation.
Stock Overview
Share Price
Company Overview
MPL offers health insurance and health services through two segments: Health Insurance and Medibank Health. Services include private health insurance, health management, and telehealth.
Disclaimers and Disclosures
Issuer
The information and opinions contained within Sandstone Insights Research were prepared by MST Financial Services Pty Ltd (ABN 54 617 475 180, AFSL 500557) ("MST").
Reliance
Whilst MST make every effort to use reliable, comprehensive information in the construction of its reports, MST make no representation, warranty or undertaking of the accuracy, timeliness or completeness of information in this report. Save for any statutory liability that cannot be excluded, MST and MST employees, representative and agents shall not be liable (whether in negligence or otherwise) for any error or inaccuracy in, or omission from, this advice or any resulting loss suffered by the recipient or any other person.
General Advice
Any advice contained within Sandstone Insights Research is general advice only and has been prepared without taking into account any person’s objectives, financial situation or needs. Any person, before acting on any advice contained within Sandstone Insights Research, should first consider consulting with a financial adviser to assess whether that advice is appropriate for their objectives, financial situation and needs.
General Disclosures
This report should be read in conjunction with MST Disclaimers and Disclosures and is published in accordance with MST Conflict Management Policy which are available on the MST website: https://www.sandstoneinsights.com.au.
Currency of Research
The recommendations made in a Sandstone Insights Research report are current as of the publication date. If you are reading a report materially after publication, it is likely that circumstances will have changed and at least some aspects of the analysis may no longer hold.
Access and Use
Any access to or use of Sandstone Insights Research is subject to the Terms of Use. By accessing or using Sandstone Insights Research you hereby agree to be bound by our Terms and Conditions and hereby liable for any monies due in payment of accessing this service. In addition you consent to us collecting and using your personal data (including cookies) in accordance with MST Privacy Policy, including for the purpose of a) setting your preferences and b) collecting readership data so MST may deliver an improved and personalised service to you. If you do not agree to MST Terms of Use and/or if you do not wish to consent to MST use of your personal data, please do not access this service.
Equities Research Methodology
Please click here for information about MST equities research methodology.